nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—Abdominal cramps—Vincristine—muscle cancer	0.0383	0.0395	CcSEcCtD
Pyridostigmine—Chest discomfort—Etoposide—muscle cancer	0.0237	0.0244	CcSEcCtD
Pyridostigmine—Lethargy—Dactinomycin—muscle cancer	0.0215	0.0221	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—muscle cancer	0.0185	0.0191	CcSEcCtD
Pyridostigmine—Cardiac arrest—Vincristine—muscle cancer	0.0179	0.0184	CcSEcCtD
Pyridostigmine—BCHE—diaphragm—muscle cancer	0.0175	0.576	CbGeAlD
Pyridostigmine—Cardiac arrest—Etoposide—muscle cancer	0.0145	0.0149	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—muscle cancer	0.0141	0.0145	CcSEcCtD
Pyridostigmine—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.014	0.0144	CcSEcCtD
Pyridostigmine—Cramp muscle—Etoposide—muscle cancer	0.0137	0.0141	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Vincristine—muscle cancer	0.0129	0.0133	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—muscle cancer	0.0129	0.0133	CcSEcCtD
Pyridostigmine—Sweating increased—Etoposide—muscle cancer	0.0128	0.0132	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—muscle cancer	0.0118	0.0122	CcSEcCtD
Pyridostigmine—Alopecia—Vincristine—muscle cancer	0.0115	0.0118	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Methotrexate—muscle cancer	0.0112	0.0115	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—muscle cancer	0.011	0.0113	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—muscle cancer	0.0108	0.0111	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—muscle cancer	0.0106	0.0109	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Methotrexate—muscle cancer	0.0105	0.0109	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Etoposide—muscle cancer	0.0105	0.0108	CcSEcCtD
Pyridostigmine—Agitation—Vincristine—muscle cancer	0.0104	0.0107	CcSEcCtD
Pyridostigmine—Vertigo—Vincristine—muscle cancer	0.0102	0.0105	CcSEcCtD
Pyridostigmine—Convulsion—Vincristine—muscle cancer	0.0098	0.0101	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—muscle cancer	0.00968	0.00998	CcSEcCtD
Pyridostigmine—Myalgia—Vincristine—muscle cancer	0.00963	0.00993	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—muscle cancer	0.00953	0.00983	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00941	0.00971	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—muscle cancer	0.0093	0.00959	CcSEcCtD
Pyridostigmine—Lethargy—Methotrexate—muscle cancer	0.0093	0.00959	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—muscle cancer	0.00912	0.0094	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Vincristine—muscle cancer	0.00893	0.0092	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—muscle cancer	0.00881	0.00909	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—muscle cancer	0.00874	0.00902	CcSEcCtD
Pyridostigmine—Hypotension—Vincristine—muscle cancer	0.00863	0.0089	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—muscle cancer	0.00852	0.00878	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00845	0.00871	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00841	0.00867	CcSEcCtD
Pyridostigmine—Paraesthesia—Vincristine—muscle cancer	0.00829	0.00855	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—muscle cancer	0.00823	0.00849	CcSEcCtD
Pyridostigmine—Abdominal pain—Dactinomycin—muscle cancer	0.00817	0.00842	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—muscle cancer	0.00805	0.00831	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—muscle cancer	0.00805	0.00831	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—muscle cancer	0.00794	0.00819	CcSEcCtD
Pyridostigmine—Asthma—Methotrexate—muscle cancer	0.00788	0.00812	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—muscle cancer	0.00761	0.00785	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vincristine—muscle cancer	0.00755	0.00779	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—muscle cancer	0.00754	0.00778	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—muscle cancer	0.0075	0.00774	CcSEcCtD
Pyridostigmine—Asthenia—Dactinomycin—muscle cancer	0.00741	0.00765	CcSEcCtD
Pyridostigmine—Abdominal pain—Vincristine—muscle cancer	0.0073	0.00753	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—muscle cancer	0.00723	0.00746	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—muscle cancer	0.00723	0.00746	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—muscle cancer	0.00707	0.00729	CcSEcCtD
Pyridostigmine—Drowsiness—Methotrexate—muscle cancer	0.00702	0.00724	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—muscle cancer	0.00699	0.00721	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—muscle cancer	0.00687	0.00708	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—muscle cancer	0.00682	0.00703	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vincristine—muscle cancer	0.0068	0.00701	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—muscle cancer	0.00672	0.00693	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—muscle cancer	0.00665	0.00686	CcSEcCtD
Pyridostigmine—Epistaxis—Methotrexate—muscle cancer	0.00663	0.00683	CcSEcCtD
Pyridostigmine—Asthenia—Vincristine—muscle cancer	0.00662	0.00683	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—muscle cancer	0.00657	0.00678	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—muscle cancer	0.00656	0.00677	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—muscle cancer	0.00652	0.00672	CcSEcCtD
Pyridostigmine—Diarrhoea—Vincristine—muscle cancer	0.00632	0.00651	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—muscle cancer	0.0063	0.0065	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—muscle cancer	0.00616	0.00636	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—muscle cancer	0.00614	0.00633	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—muscle cancer	0.00612	0.00631	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—muscle cancer	0.00608	0.00627	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—muscle cancer	0.00594	0.00613	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—muscle cancer	0.00591	0.0061	CcSEcCtD
Pyridostigmine—Vomiting—Vincristine—muscle cancer	0.00587	0.00605	CcSEcCtD
Pyridostigmine—Rash—Vincristine—muscle cancer	0.00582	0.006	CcSEcCtD
Pyridostigmine—Dermatitis—Vincristine—muscle cancer	0.00582	0.006	CcSEcCtD
Pyridostigmine—Headache—Vincristine—muscle cancer	0.00578	0.00596	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—muscle cancer	0.00574	0.00592	CcSEcCtD
Pyridostigmine—Alopecia—Methotrexate—muscle cancer	0.00557	0.00575	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—muscle cancer	0.00556	0.00573	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—muscle cancer	0.00551	0.00568	CcSEcCtD
Pyridostigmine—Nausea—Vincristine—muscle cancer	0.00548	0.00566	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00543	0.0056	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—muscle cancer	0.00537	0.00553	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—muscle cancer	0.00512	0.00528	CcSEcCtD
Pyridostigmine—Vertigo—Methotrexate—muscle cancer	0.00493	0.00509	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—muscle cancer	0.00482	0.00498	CcSEcCtD
Pyridostigmine—Convulsion—Methotrexate—muscle cancer	0.00476	0.0049	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—muscle cancer	0.00476	0.0049	CcSEcCtD
Pyridostigmine—Rash—Etoposide—muscle cancer	0.00472	0.00486	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—muscle cancer	0.00471	0.00486	CcSEcCtD
Pyridostigmine—Headache—Etoposide—muscle cancer	0.00469	0.00483	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—muscle cancer	0.00468	0.00483	CcSEcCtD
Pyridostigmine—Myalgia—Methotrexate—muscle cancer	0.00467	0.00482	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—muscle cancer	0.00457	0.00471	CcSEcCtD
Pyridostigmine—Confusional state—Methotrexate—muscle cancer	0.00452	0.00466	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—muscle cancer	0.00444	0.00458	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—muscle cancer	0.00437	0.0045	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Methotrexate—muscle cancer	0.00433	0.00447	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—muscle cancer	0.00427	0.0044	CcSEcCtD
Pyridostigmine—Hypotension—Methotrexate—muscle cancer	0.00419	0.00432	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—muscle cancer	0.00418	0.00431	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—muscle cancer	0.00412	0.00425	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00408	0.00421	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—muscle cancer	0.00405	0.00417	CcSEcCtD
Pyridostigmine—Paraesthesia—Methotrexate—muscle cancer	0.00402	0.00415	CcSEcCtD
Pyridostigmine—Somnolence—Methotrexate—muscle cancer	0.00398	0.00411	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—muscle cancer	0.00391	0.00403	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00375	0.00387	CcSEcCtD
Pyridostigmine—Feeling abnormal—Methotrexate—muscle cancer	0.00369	0.00381	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00366	0.00378	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—muscle cancer	0.00362	0.00374	CcSEcCtD
Pyridostigmine—Urticaria—Methotrexate—muscle cancer	0.00356	0.00367	CcSEcCtD
Pyridostigmine—Abdominal pain—Methotrexate—muscle cancer	0.00354	0.00365	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00353	0.00364	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—muscle cancer	0.00348	0.00359	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—muscle cancer	0.00345	0.00356	CcSEcCtD
Pyridostigmine—Hypersensitivity—Methotrexate—muscle cancer	0.0033	0.0034	CcSEcCtD
Pyridostigmine—Asthenia—Methotrexate—muscle cancer	0.00321	0.00331	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—muscle cancer	0.0032	0.0033	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00317	0.00327	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—muscle cancer	0.00308	0.00318	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—muscle cancer	0.00307	0.00316	CcSEcCtD
Pyridostigmine—Diarrhoea—Methotrexate—muscle cancer	0.00307	0.00316	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—muscle cancer	0.00286	0.00295	CcSEcCtD
Pyridostigmine—Vomiting—Methotrexate—muscle cancer	0.00285	0.00294	CcSEcCtD
Pyridostigmine—Rash—Methotrexate—muscle cancer	0.00282	0.00291	CcSEcCtD
Pyridostigmine—Dermatitis—Methotrexate—muscle cancer	0.00282	0.00291	CcSEcCtD
Pyridostigmine—Headache—Methotrexate—muscle cancer	0.00281	0.00289	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—muscle cancer	0.00278	0.00287	CcSEcCtD
Pyridostigmine—Nausea—Methotrexate—muscle cancer	0.00266	0.00274	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—muscle cancer	0.00265	0.00274	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—muscle cancer	0.00247	0.00254	CcSEcCtD
Pyridostigmine—ACHE—tendon—muscle cancer	0.00246	0.081	CbGeAlD
Pyridostigmine—Rash—Doxorubicin—muscle cancer	0.00245	0.00252	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—muscle cancer	0.00244	0.00252	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—muscle cancer	0.00243	0.00251	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—muscle cancer	0.0023	0.00238	CcSEcCtD
Pyridostigmine—ACHE—testis—muscle cancer	0.00203	0.0671	CbGeAlD
Pyridostigmine—BCHE—smooth muscle tissue—muscle cancer	0.00161	0.053	CbGeAlD
Pyridostigmine—BCHE—cardiac atrium—muscle cancer	0.00138	0.0457	CbGeAlD
Pyridostigmine—BCHE—bone marrow—muscle cancer	0.00117	0.0386	CbGeAlD
Pyridostigmine—BCHE—vagina—muscle cancer	0.00112	0.0369	CbGeAlD
Pyridostigmine—CYP3A4—renal system—muscle cancer	0.00104	0.0343	CbGeAlD
Pyridostigmine—BCHE—head—muscle cancer	0.00103	0.0341	CbGeAlD
Pyridostigmine—BCHE—testis—muscle cancer	0.000999	0.033	CbGeAlD
